Everest Medicines Limited (HKG:1952)
35.60
-1.14 (-3.10%)
At close: Mar 9, 2026
Everest Medicines Employees
Everest Medicines had 665 employees as of December 31, 2024. The number of employees increased by 233 or 53.94% compared to the previous year.
Employees
665
Change (1Y)
233
Growth (1Y)
53.94%
Revenue / Employee
1.29M HKD
Profits / Employee
-999.79K HKD
Market Cap
12.58B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 665 | 233 | 53.94% |
| Dec 31, 2023 | 432 | 67 | 18.36% |
| Dec 31, 2022 | 365 | -40 | -9.88% |
| Dec 31, 2021 | 405 | 256 | 171.81% |
| Dec 31, 2020 | 149 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascletis Pharma | 208 |
| Keymed Biosciences | 1,469 |
| HBM Holdings | 210 |
| Shanghai Haohai Biological Technology | 2,156 |
| CStone Pharmaceuticals | 131 |
| Ascentage Pharma Group International | 605 |
| Zai Lab | 1,869 |
| Abbisko Cayman | 226 |
Everest Medicines News
- 4 weeks ago - Everest Medicines Advances With Major Licensing Deal, New Drug Application Approval - Benzinga
- 1 year ago - AI-powered Cancer Vaccine In The Works - Benzinga
- 1 year ago - Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update - Benzinga